Skip to main content
logo
Virax Biolabs Group Limited (VRAX)
NASDAQ: VRAX · Real-Time Price · USD
0.3925
-0.0101 (-2.51%)
At close: Dec 1, 2025, 4:00 PM EST
0.3910
-0.0015 (-0.38%)
After-hours: Dec 1, 2025, 4:00 PM EST

Virax Biolabs Group Revenue

In the fiscal year ending March 31, 2025, Virax Biolabs Group had annual revenue of $6.33K, down -95.95%. Virax Biolabs Group had revenue of $1.38K in the half year ending March 31, 2025, a decrease of -50.80%.

Revenue (ttm)
$6.33K
Revenue Growth
-95.95%
P/S Ratio
237.24
Revenue / Employee
$333
Employees
19
Market Cap
1.70M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Mar 31, 20256.33K-150.09K-95.95%
Mar 31, 2024156.42K147.86K1,727.11%
Mar 31, 20238.56K--
Mar 31, 2022---
Mar 31, 2021123.82K23.94K23.97%
Mar 31, 2020 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
UnitedHealth Group435.16B
Johnson & Johnson92.15B
Merck & Co.64.24B
AbbVie59.64B
Eli Lilly and Company59.42B
AstraZeneca58.13B
Novartis AG56.37B
Novo Nordisk49.58B
Revenue Rankings

VRAX News

More News